NO166940C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen.Info
- Publication number
- NO166940C NO166940C NO872004A NO872004A NO166940C NO 166940 C NO166940 C NO 166940C NO 872004 A NO872004 A NO 872004A NO 872004 A NO872004 A NO 872004A NO 166940 C NO166940 C NO 166940C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- lower alkyl
- imidazole derivatives
- alkyl
- substituted imidazole
- Prior art date
Links
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 239000013067 intermediate product Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- 101100448208 Human herpesvirus 6B (strain Z29) U69 gene Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Epoxy Resins (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Dental Preparations (AREA)
- Golf Clubs (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO882728A NO167735C (no) | 1986-05-15 | 1988-06-21 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4(5)-substituerte imidazol-derivater. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI862039A FI862039A0 (fi) | 1986-05-15 | 1986-05-15 | Nytt foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat. |
| FI870462A FI870462A0 (fi) | 1987-02-04 | 1987-02-04 | Foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat. |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO872004D0 NO872004D0 (no) | 1987-05-14 |
| NO872004L NO872004L (no) | 1987-11-16 |
| NO166940B NO166940B (no) | 1991-06-10 |
| NO166940C true NO166940C (no) | 1991-09-25 |
Family
ID=26157963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO872004A NO166940C (no) | 1986-05-15 | 1987-05-14 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4933359A (de) |
| EP (1) | EP0247764B1 (de) |
| JP (1) | JP2561272B2 (de) |
| KR (1) | KR950002158B1 (de) |
| AT (1) | ATE66211T1 (de) |
| AU (1) | AU600725B2 (de) |
| CA (1) | CA1299186C (de) |
| DE (1) | DE3772104D1 (de) |
| DK (1) | DK172422B1 (de) |
| ES (1) | ES2037712T3 (de) |
| FI (1) | FI81092C (de) |
| GR (1) | GR3002928T3 (de) |
| HU (1) | HU197314B (de) |
| IE (1) | IE59609B1 (de) |
| IL (1) | IL82541A (de) |
| NO (1) | NO166940C (de) |
| NZ (1) | NZ220306A (de) |
| PT (1) | PT84881B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2225782A (en) * | 1988-12-09 | 1990-06-13 | Farmos Group Limited | Imidazole derivatives useful for treatment of diabetes |
| CA1321751C (en) * | 1989-02-21 | 1993-08-31 | Eugene C. Crichlow | Mechanism mediating ruminal stasis in ruminal lactic acidosis |
| GB2244431A (en) * | 1990-05-31 | 1991-12-04 | Farmos Oy | Treatment of age related memory impairment and other cognitive disorders |
| FR2669030B1 (fr) * | 1990-11-14 | 1992-12-31 | Adir | Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| GB9127050D0 (en) * | 1991-12-20 | 1992-02-19 | Orion Yhtymae Oy | Substituted imidazole derivatives and their preparation and use |
| GB9312669D0 (en) | 1993-06-18 | 1993-08-04 | Orion Yhtymae Oy | New opticla isomers |
| FR2735776B1 (fr) * | 1995-06-22 | 1997-07-18 | Synthelabo | Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique |
| GB9520150D0 (en) | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
| AU3033100A (en) * | 1999-01-18 | 2000-08-01 | Boehringer Ingelheim International Gmbh | Substituted imidazoles, their preparation and use |
| US6388090B2 (en) * | 2000-01-14 | 2002-05-14 | Orion Corporation | Imidazole derivatives |
| CA2408290A1 (en) * | 2000-05-08 | 2001-11-15 | Orion Corporation | New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| FR2839719B1 (fr) * | 2002-05-16 | 2004-08-06 | Pf Medicament | Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments |
| US8188126B2 (en) | 2002-05-16 | 2012-05-29 | Pierre Fabre Medicament | Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
| EP1942903A4 (de) * | 2005-08-30 | 2011-01-12 | Univ Kingston | Potenzierung der therapeutischen wirkung eines opioid-rezeptor-agonisten und/oder hemmung oder umkehr der toleranz für opioid-rezeptor-agonisten mit einer ultraniedrigen dosis eines alpha-2-rezeptor-antagonisten |
| CL2008003553A1 (es) * | 2007-12-05 | 2009-11-27 | Grindeks Jsc | Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso |
| WO2011009928A1 (en) * | 2009-07-24 | 2011-01-27 | Dsm Pharma Chemicals Regensburg Gmbh | Indane derivatives for use as intermediates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7908922A (nl) * | 1979-12-12 | 1981-07-16 | Akzo Nv | Carboximidamide derivaten. |
| US4480118A (en) * | 1981-01-13 | 1984-10-30 | Sumitomo Chemical Company, Limited | Carboxylic acid ester and an insecticidal and/or acaricidal composition containing the same |
| DE3271003D1 (en) * | 1981-09-15 | 1986-06-12 | Ici Plc | Amino-substituted tetralins and related homocyclic compounds |
| US4661522A (en) * | 1984-05-24 | 1987-04-28 | Akzo N.V. | Cycloalkane-indene-carboximidamide derivatives |
| GB2167408B (en) * | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
-
1987
- 1987-04-15 FI FI871655A patent/FI81092C/fi not_active IP Right Cessation
- 1987-04-24 DK DK198702082A patent/DK172422B1/da not_active IP Right Cessation
- 1987-05-14 HU HU872181A patent/HU197314B/hu unknown
- 1987-05-14 NZ NZ220306A patent/NZ220306A/xx unknown
- 1987-05-14 KR KR1019870004746A patent/KR950002158B1/ko not_active Expired - Lifetime
- 1987-05-14 DE DE8787304304T patent/DE3772104D1/de not_active Expired - Lifetime
- 1987-05-14 ES ES198787304304T patent/ES2037712T3/es not_active Expired - Lifetime
- 1987-05-14 AT AT87304304T patent/ATE66211T1/de not_active IP Right Cessation
- 1987-05-14 IE IE125887A patent/IE59609B1/en not_active IP Right Cessation
- 1987-05-14 JP JP62118077A patent/JP2561272B2/ja not_active Expired - Lifetime
- 1987-05-14 EP EP87304304A patent/EP0247764B1/de not_active Expired - Lifetime
- 1987-05-14 NO NO872004A patent/NO166940C/no unknown
- 1987-05-14 US US07/049,882 patent/US4933359A/en not_active Expired - Lifetime
- 1987-05-15 CA CA000537323A patent/CA1299186C/en not_active Expired - Lifetime
- 1987-05-15 AU AU73102/87A patent/AU600725B2/en not_active Ceased
- 1987-05-15 IL IL82541A patent/IL82541A/xx not_active IP Right Cessation
- 1987-05-15 PT PT84881A patent/PT84881B/pt unknown
-
1989
- 1989-11-06 US US07/431,959 patent/US5026868A/en not_active Expired - Lifetime
-
1991
- 1991-10-17 GR GR91401554T patent/GR3002928T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ220306A (en) | 1990-02-26 |
| PT84881A (en) | 1987-06-01 |
| KR880009941A (ko) | 1988-10-06 |
| HUT45234A (en) | 1988-06-28 |
| ATE66211T1 (de) | 1991-08-15 |
| AU600725B2 (en) | 1990-08-23 |
| IE59609B1 (en) | 1994-03-09 |
| DK208287D0 (da) | 1987-04-24 |
| AU7310287A (en) | 1987-11-19 |
| DK208287A (da) | 1987-11-16 |
| FI871655A0 (fi) | 1987-04-15 |
| DE3772104D1 (de) | 1991-09-19 |
| JP2561272B2 (ja) | 1996-12-04 |
| JPS62289566A (ja) | 1987-12-16 |
| US5026868A (en) | 1991-06-25 |
| DK172422B1 (da) | 1998-06-08 |
| IL82541A0 (en) | 1987-11-30 |
| NO166940B (no) | 1991-06-10 |
| US4933359A (en) | 1990-06-12 |
| KR950002158B1 (ko) | 1995-03-14 |
| FI871655A7 (fi) | 1987-11-16 |
| GR3002928T3 (en) | 1993-01-25 |
| NO872004D0 (no) | 1987-05-14 |
| IE871258L (en) | 1987-11-15 |
| IL82541A (en) | 1992-06-21 |
| EP0247764A1 (de) | 1987-12-02 |
| FI81092C (fi) | 1990-09-10 |
| HU197314B (en) | 1989-03-28 |
| PT84881B (pt) | 1990-02-08 |
| NO872004L (no) | 1987-11-16 |
| ES2037712T3 (es) | 1993-07-01 |
| FI81092B (fi) | 1990-05-31 |
| CA1299186C (en) | 1992-04-21 |
| EP0247764B1 (de) | 1991-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO166940C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen. | |
| EE200000504A (et) | Bensofurüül-a-pürooni derivaadid, farmatseutilinekompositsioon, lipiidide ainevahetuse kiirendaja,triglütseriidi biosünteesi inhibiitor, vere triglütseriiditaset alandav toimeaine, vere HDL taset tõstev toimeaine, arterioskleroosi profülaktiline to | |
| NO168582C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme dihydrobenzofuran- og chroman-carboxamidderivater | |
| ES2112870T3 (es) | Derivados de acido glicirretico. | |
| FI942882A7 (fi) | Substituoituja imidatsolijohdannaisia ja niiden valmistus ja käyttö | |
| IE49496B1 (en) | A 1,4-dihydropyridine derivative,its preparation and pharmaceutical compositions containing it | |
| DE69110828D1 (de) | Heterozyklische Aminderivate, deren Herstellung und deren Verwendung. | |
| ATE90348T1 (de) | Pyrido(2,3-d>pyrimidin-derivate. | |
| NO162421C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylinderivater og syreaddisjonssalter derav. | |
| AP9801410A0 (en) | Indoline derivatives useful as 5-HT-2C receptor antagonists. | |
| DE3883891D1 (de) | Benzimidazol-Derivate und Verfahren zu deren Herstellung. | |
| AU664093B2 (en) | Arylpiperidine and arylpiperazine alkylbenzyl alcohol derivatives as antipsychotics | |
| CA2192596A1 (en) | 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety | |
| NZ240298A (en) | 4-(4- and/or 6-(trifluoromethyl)pyrid-2-)piperazin-1-ylalkyl substituted lactam derivatives | |
| DK243487A (da) | Heterocyclisk-aromatiske forbindelser, deres fremstilling og farmaceutiske anvendelse | |
| ATE9896T1 (de) | Substituierte 3-aryl-2-cycloalken-1-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| PT92175A (pt) | Processo para a preparacao de 3-amino-sidnoniminas substituidas e de produtos intermediarios farmacologicamente activos | |
| IL79280A (en) | 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them |